 | • レポートコード：QAF27545 • 出版社/出版日：QYResearch / 2021年3月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の加齢性黄斑変性症治療薬市場について種類別（ルセンティス、アイリーア、アバスチン、その他）、用途別（病院、診療所、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・加齢性黄斑変性症治療薬市場の概要 ・世界の主要地域別加齢性黄斑変性症治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の加齢性黄斑変性症治療薬市場規模2016-2021：種類別（ルセンティス、アイリーア、アバスチン、その他） ・世界の加齢性黄斑変性症治療薬市場予測2012-2027：種類別（ルセンティス、アイリーア、アバスチン、その他） ・世界の加齢性黄斑変性症治療薬市場規模2016-2021：用途別（病院、診療所、その他） ・世界の加齢性黄斑変性症治療薬市場予測2012-2027：用途別（病院、診療所、その他） ・加齢性黄斑変性症治療薬のアメリカ市場規模と予測2016-2021 ・加齢性黄斑変性症治療薬のヨーロッパ市場規模と予測2016-2021 ・加齢性黄斑変性症治療薬の中国市場規模と予測2016-2021 ・加齢性黄斑変性症治療薬の日本市場規模と予測2016-2021 ・加齢性黄斑変性症治療薬の東南アジア市場規模と予測2016-2021 ・加齢性黄斑変性症治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Regeneron Pharmaceuticals、Bayer HealthCare、Novartis、Roche、Kanghong Pharma） ・加齢性黄斑変性症治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・加齢性黄斑変性症治療薬の市場動向・機会・課題 ・調査の結論 |
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
Market Analysis and Insights: Global Age Related Macular Degeneration Drug Market
The global Age Related Macular Degeneration Drug market was valued at US$ 7725.7 in 2020 and will reach US$ 10900 million by the end of 2027, growing at a CAGR of 5.9% during 2022-2027.
Global Age Related Macular Degeneration Drug Scope and Market Size
The global Age Related Macular Degeneration Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Age Related Macular Degeneration Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Lucentis
Eylea
Avastin
Other
Segment by Application
Hospitals
Clinics
Other
The Age Related Macular Degeneration Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Age Related Macular Degeneration Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
1 Age Related Macular Degeneration Drug Market Overview
1.1 Age Related Macular Degeneration Drug Product Scope
1.2 Age Related Macular Degeneration Drug Segment by Type
1.2.1 Global Age Related Macular Degeneration Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Other
1.3 Age Related Macular Degeneration Drug Segment by Application
1.3.1 Global Age Related Macular Degeneration Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Age Related Macular Degeneration Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Age Related Macular Degeneration Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Age Related Macular Degeneration Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Age Related Macular Degeneration Drug Price Trends (2016-2027)
2 Age Related Macular Degeneration Drug Estimates and Forecasts by Region
2.1 Global Age Related Macular Degeneration Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Age Related Macular Degeneration Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Age Related Macular Degeneration Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2016-2021)
2.3 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Age Related Macular Degeneration Drug Estimates and Projections (2016-2027)
2.4.2 Europe Age Related Macular Degeneration Drug Estimates and Projections (2016-2027)
2.4.3 China Age Related Macular Degeneration Drug Estimates and Projections (2016-2027)
2.4.4 Japan Age Related Macular Degeneration Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Age Related Macular Degeneration Drug Estimates and Projections (2016-2027)
2.4.6 India Age Related Macular Degeneration Drug Estimates and Projections (2016-2027)
3 Global Age Related Macular Degeneration Drug Competition Landscape by Players
3.1 Global Top Age Related Macular Degeneration Drug Players by Sales (2016-2021)
3.2 Global Top Age Related Macular Degeneration Drug Players by Revenue (2016-2021)
3.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2020)
3.4 Global Age Related Macular Degeneration Drug Average Price by Company (2016-2021)
3.5 Manufacturers Age Related Macular Degeneration Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Age Related Macular Degeneration Drug Market Size by Type
4.1 Global Age Related Macular Degeneration Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Age Related Macular Degeneration Drug Price by Type (2016-2021)
4.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Type (2022-2027)
5 Global Age Related Macular Degeneration Drug Market Size by Application
5.1 Global Age Related Macular Degeneration Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Age Related Macular Degeneration Drug Price by Application (2016-2021)
5.2 Global Age Related Macular Degeneration Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Age Related Macular Degeneration Drug Price Forecast by Application (2022-2027)
6 North America Age Related Macular Degeneration Drug Market Facts & Figures
6.1 North America Age Related Macular Degeneration Drug Sales by Company
6.1.1 North America Age Related Macular Degeneration Drug Sales by Company (2016-2021)
6.1.2 North America Age Related Macular Degeneration Drug Revenue by Company (2016-2021)
6.2 North America Age Related Macular Degeneration Drug Sales Breakdown by Type
6.2.1 North America Age Related Macular Degeneration Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Age Related Macular Degeneration Drug Sales Breakdown by Type (2022-2027)
6.3 North America Age Related Macular Degeneration Drug Sales Breakdown by Application
6.3.1 North America Age Related Macular Degeneration Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Age Related Macular Degeneration Drug Sales Breakdown by Application (2022-2027)
7 Europe Age Related Macular Degeneration Drug Market Facts & Figures
7.1 Europe Age Related Macular Degeneration Drug Sales by Company
7.1.1 Europe Age Related Macular Degeneration Drug Sales by Company (2016-2021)
7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Company (2016-2021)
7.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type
7.2.1 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Age Related Macular Degeneration Drug Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)
8 China Age Related Macular Degeneration Drug Market Facts & Figures
8.1 China Age Related Macular Degeneration Drug Sales by Company
8.1.1 China Age Related Macular Degeneration Drug Sales by Company (2016-2021)
8.1.2 China Age Related Macular Degeneration Drug Revenue by Company (2016-2021)
8.2 China Age Related Macular Degeneration Drug Sales Breakdown by Type
8.2.1 China Age Related Macular Degeneration Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Age Related Macular Degeneration Drug Sales Breakdown by Type (2022-2027)
8.3 China Age Related Macular Degeneration Drug Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Age Related Macular Degeneration Drug Market Facts & Figures
9.1 Japan Age Related Macular Degeneration Drug Sales by Company
9.1.1 Japan Age Related Macular Degeneration Drug Sales by Company (2016-2021)
9.1.2 Japan Age Related Macular Degeneration Drug Revenue by Company (2016-2021)
9.2 Japan Age Related Macular Degeneration Drug Sales Breakdown by Type
9.2.1 Japan Age Related Macular Degeneration Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Age Related Macular Degeneration Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Age Related Macular Degeneration Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Age Related Macular Degeneration Drug Market Facts & Figures
10.1 Southeast Asia Age Related Macular Degeneration Drug Sales by Company
10.1.1 Southeast Asia Age Related Macular Degeneration Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Age Related Macular Degeneration Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Age Related Macular Degeneration Drug Sales Breakdown by Type
10.2.1 Southeast Asia Age Related Macular Degeneration Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Age Related Macular Degeneration Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Age Related Macular Degeneration Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Age Related Macular Degeneration Drug Market Facts & Figures
11.1 India Age Related Macular Degeneration Drug Sales by Company
11.1.1 India Age Related Macular Degeneration Drug Sales by Company (2016-2021)
11.1.2 India Age Related Macular Degeneration Drug Revenue by Company (2016-2021)
11.2 India Age Related Macular Degeneration Drug Sales Breakdown by Type
11.2.1 India Age Related Macular Degeneration Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Age Related Macular Degeneration Drug Sales Breakdown by Type (2022-2027)
11.3 India Age Related Macular Degeneration Drug Sales Breakdown by Application
11.3.1 India Age Related Macular Degeneration Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Age Related Macular Degeneration Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Age Related Macular Degeneration Drug Business
12.1 Regeneron Pharmaceuticals
12.1.1 Regeneron Pharmaceuticals Corporation Information
12.1.2 Regeneron Pharmaceuticals Business Overview
12.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
12.1.5 Regeneron Pharmaceuticals Recent Development
12.2 Bayer HealthCare
12.2.1 Bayer HealthCare Corporation Information
12.2.2 Bayer HealthCare Business Overview
12.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
12.2.5 Bayer HealthCare Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Age Related Macular Degeneration Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Roche
12.4.1 Roche Corporation Information
12.4.2 Roche Business Overview
12.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Roche Age Related Macular Degeneration Drug Products Offered
12.4.5 Roche Recent Development
12.5 Kanghong Pharma
12.5.1 Kanghong Pharma Corporation Information
12.5.2 Kanghong Pharma Business Overview
12.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
12.5.5 Kanghong Pharma Recent Development
…
13 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
13.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
13.4 Age Related Macular Degeneration Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Age Related Macular Degeneration Drug Distributors List
14.3 Age Related Macular Degeneration Drug Customers
15 Market Dynamics
15.1 Age Related Macular Degeneration Drug Market Trends
15.2 Age Related Macular Degeneration Drug Drivers
15.3 Age Related Macular Degeneration Drug Market Challenges
15.4 Age Related Macular Degeneration Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Age Related Macular Degeneration Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Age Related Macular Degeneration Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Age Related Macular Degeneration Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Age Related Macular Degeneration Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2016-2021)
Table 6. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Age Related Macular Degeneration Drug Revenue Share by Region (2016-2021)
Table 8. Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Age Related Macular Degeneration Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Age Related Macular Degeneration Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Age Related Macular Degeneration Drug Sales Share by Company (2016-2021)
Table 14. Global Age Related Macular Degeneration Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Age Related Macular Degeneration Drug Revenue Share by Company (2016-2021)
Table 16. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Drug as of 2020)
Table 17. Global Age Related Macular Degeneration Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Age Related Macular Degeneration Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Age Related Macular Degeneration Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Age Related Macular Degeneration Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Age Related Macular Degeneration Drug Sales Share by Type (2016-2021)
Table 23. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Age Related Macular Degeneration Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Age Related Macular Degeneration Drug Sales Share by Type (2022-2027)
Table 26. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Age Related Macular Degeneration Drug Revenue Share by Type (2022-2027)
Table 28. Global Age Related Macular Degeneration Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Age Related Macular Degeneration Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Age Related Macular Degeneration Drug Sales Share by Application (2016-2021)
Table 31. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Age Related Macular Degeneration Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Age Related Macular Degeneration Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Age Related Macular Degeneration Drug Sales Share by Application (2022-2027)
Table 35. Global Age Related Macular Degeneration Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Age Related Macular Degeneration Drug Revenue Share by Application (2022-2027)
Table 37. Global Age Related Macular Degeneration Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Age Related Macular Degeneration Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Age Related Macular Degeneration Drug Sales Market Share by Company (2016-2021)
Table 40. North America Age Related Macular Degeneration Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Age Related Macular Degeneration Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Age Related Macular Degeneration Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
Table 44. North America Age Related Macular Degeneration Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2022-2027)
Table 46. North America Age Related Macular Degeneration Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
Table 48. North America Age Related Macular Degeneration Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Age Related Macular Degeneration Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Age Related Macular Degeneration Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Age Related Macular Degeneration Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Age Related Macular Degeneration Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Age Related Macular Degeneration Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Age Related Macular Degeneration Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Age Related Macular Degeneration Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Age Related Macular Degeneration Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2022-2027)
Table 62. China Age Related Macular Degeneration Drug Sales (K Units) by Company (2016-2021)
Table 63. China Age Related Macular Degeneration Drug Sales Market Share by Company (2016-2021)
Table 64. China Age Related Macular Degeneration Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Age Related Macular Degeneration Drug Revenue Market Share by Company (2016-2021)
Table 66. China Age Related Macular Degeneration Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
Table 68. China Age Related Macular Degeneration Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Age Related Macular Degeneration Drug Sales Market Share by Type (2022-2027)
Table 70. China Age Related Macular Degeneration Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
Table 72. China Age Related Macular Degeneration Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Age Related Macular Degeneration Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Age Related Macular Degeneration Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Age Related Macular Degeneration Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Age Related Macular Degeneration Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Age Related Macular Degeneration Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Age Related Macular Degeneration Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Age Related Macular Degeneration Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Age Related Macular Degeneration Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Age Related Macular Degeneration Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Age Related Macular Degeneration Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Age Related Macular Degeneration Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Age Related Macular Degeneration Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Age Related Macular Degeneration Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Age Related Macular Degeneration Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Age Related Macular Degeneration Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Age Related Macular Degeneration Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Age Related Macular Degeneration Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Age Related Macular Degeneration Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Application (2022-2027)
Table 98. India Age Related Macular Degeneration Drug Sales (K Units) by Company (2016-2021)
Table 99. India Age Related Macular Degeneration Drug Sales Market Share by Company (2016-2021)
Table 100. India Age Related Macular Degeneration Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Age Related Macular Degeneration Drug Revenue Market Share by Company (2016-2021)
Table 102. India Age Related Macular Degeneration Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Age Related Macular Degeneration Drug Sales Market Share by Type (2016-2021)
Table 104. India Age Related Macular Degeneration Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Age Related Macular Degeneration Drug Sales Market Share by Type (2022-2027)
Table 106. India Age Related Macular Degeneration Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Age Related Macular Degeneration Drug Sales Market Share by Application (2016-2021)
Table 108. India Age Related Macular Degeneration Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Age Related Macular Degeneration Drug Sales Market Share by Application (2022-2027)
Table 110. Regeneron Pharmaceuticals Corporation Information
Table 111. Regeneron Pharmaceuticals Description and Business Overview
Table 112. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 114. Regeneron Pharmaceuticals Recent Development
Table 115. Bayer HealthCare Corporation Information
Table 116. Bayer HealthCare Description and Business Overview
Table 117. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 119. Bayer HealthCare Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Age Related Macular Degeneration Drug Product
Table 124. Novartis Recent Development
Table 125. Roche Corporation Information
Table 126. Roche Description and Business Overview
Table 127. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Roche Age Related Macular Degeneration Drug Product
Table 129. Roche Recent Development
Table 130. Kanghong Pharma Corporation Information
Table 131. Kanghong Pharma Description and Business Overview
Table 132. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Kanghong Pharma Age Related Macular Degeneration Drug Product
Table 134. Kanghong Pharma Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Age Related Macular Degeneration Drug Distributors List
Table 138. Age Related Macular Degeneration Drug Customers List
Table 139. Age Related Macular Degeneration Drug Market Trends
Table 140. Age Related Macular Degeneration Drug Market Drivers
Table 141. Age Related Macular Degeneration Drug Market Challenges
Table 142. Age Related Macular Degeneration Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Age Related Macular Degeneration Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Other Examples
Figure 9. Global Age Related Macular Degeneration Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Age Related Macular Degeneration Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Age Related Macular Degeneration Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Age Related Macular Degeneration Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Age Related Macular Degeneration Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Age Related Macular Degeneration Drug Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Age Related Macular Degeneration Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Age Related Macular Degeneration Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Age Related Macular Degeneration Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Age Related Macular Degeneration Drug Players Market Share by Revenue in Age Related Macular Degeneration Drug: 2016 & 2020
Figure 28. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Age Related Macular Degeneration Drug Revenue Share by Type (2016-2021)
Figure 30. Global Age Related Macular Degeneration Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Age Related Macular Degeneration Drug Revenue Share by Application (2016-2021)
Figure 32. Global Age Related Macular Degeneration Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Age Related Macular Degeneration Drug Sales Market Share by Type in 2020
Figure 34. North America Age Related Macular Degeneration Drug Sales Market Share by Application in 2020
Figure 35. Europe Age Related Macular Degeneration Drug Sales Market Share by Type in 2020
Figure 36. Europe Age Related Macular Degeneration Drug Sales Market Share by Application in 2020
Figure 37. China Age Related Macular Degeneration Drug Sales Market Share by Type in 2020
Figure 38. China Age Related Macular Degeneration Drug Sales Market Share by Application in 2020
Figure 39. Japan Age Related Macular Degeneration Drug Sales Market Share by Type in 2020
Figure 40. Japan Age Related Macular Degeneration Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Age Related Macular Degeneration Drug Sales Market Share by Application in 2020
Figure 43. India Age Related Macular Degeneration Drug Sales Market Share by Type in 2020
Figure 44. India Age Related Macular Degeneration Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure 47. Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure 48. Age Related Macular Degeneration Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の加齢黄斑変性症用治療市場規模・現状・予測（2021年-2027年） Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. Market Analysis and Insights: Global Age Related Mac…- 世界の加齢黄斑変性症（AMD）治療市場規模・現状・予測（2021年-2027年） Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected. Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing t…
- 加齢黄斑変性症(AMD)治療のグローバル市場：規模・現状・予測2019-2025 Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to…
- 加齢黄斑変性症(AMD)治療のグローバル市場：規模・現状・予測2019-2025 Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to…
- 加齢黄斑変性症(AMD)のグローバル市場調査 2019年 The global Age-related Macular Degeneration market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Age-related Macular Degeneration volume and value at global level, regional level and company level. From …